Lizzi C. Lee speaks with Gary Rieschel about what's behind China's biotech boom, potential risks, and long-term global ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...

BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...

The import ban on Illumina’s sequencers follows the San Diego biotech’s placement on the MOFCOM’s ‘Unreliable Entity List’ on ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries to ...